Foreign body aspiration into the trachea or bronchi is a common accidental emergency in infants and young children. In recent years, cases of children accidentally inhaling foods like jelly, peanuts,…
I. Fever Management Principles Fever Classification: Low-grade: 37.5–38°C (99.5–100.4°F) Moderate: 38–39°C (100.4–102.2°F) High-grade: ≥39°C (102.2°F) Mild to moderate fever aids immune response against pathogens and supports development. When to Use…
When a foreign body enters the lower respiratory tract, it typically triggers violent coughing initially, followed by a variable asymptomatic period, which often leads to misdiagnosis. Symptoms vary depending on…
Part 1: Understanding Influenza (1) Virus vs. BacteriaInfluenza (flu) is caused by viruses, not bacteria. Unlike bacterial infections, which trigger immediate immune responses and can be treated with antibiotics, viruses…
Tuberculosis Rest & Nutrition: Bed rest is recommended during active disease phases. Provide a high-calorie, high-protein, vitamin-rich diet. Include lung-nourishing foods: pig lung, white fungus, tofu, mushrooms, pineapple, figs, and…
Pre-Treatment Assessment Patient Selection Consider factors such as age, performance status, and comorbidities to evaluate treatment tolerance. Patients with good performance status and no severe comorbidities are better candidates for…
The Expert Consensus on Quality Management of Tumor-Infiltrating Lymphocyte (TIL) Product Preparation outlines critical guidelines to ensure the safety, efficacy, and consistency of TIL-based therapies. Key aspects include: Background TIL therapy holds…
[Behind the 10-year life extension of the artificial heart? Take you to know about the artificial heart! 】 Moderator: Ding Ling (Liaoning Provincial Science and Technology Museum) When the heart…
The 2024 Chinese Expert Consensus on Immunotherapy for Lymphoma, developed by the Committee on Tumor Immunotherapy of the Chinese Geriatric Health Association, summarizes the application and research progress of immunotherapies in…
Follicular Lymphoma (FL) Third-Line and Beyond Therapy: T-cell engager bispecific antibodies: Added epcoritamab-bysp as a Category 2A preferred recommendation. CAR-T cell therapy: Added lisocabtagene maraleucel (CD19-targeted) as a Category 2A…